Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,093 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nucleosome destabilization by nuclear non-coding RNAs.
Fujita R, Yamamoto T, Arimura Y, Fujiwara S, Tachiwana H, Ichikawa Y, Sakata Y, Yang L, Maruyama R, Hamada M, Nakao M, Saitoh N, Kurumizaka H. Fujita R, et al. Among authors: sakata y. Commun Biol. 2020 Feb 11;3(1):60. doi: 10.1038/s42003-020-0784-9. Commun Biol. 2020. PMID: 32047236 Free PMC article.
Ribosomal protein L5 facilitates rDNA-bundled condensate and nucleolar assembly.
Matsumori H, Watanabe K, Tachiwana H, Fujita T, Ito Y, Tokunaga M, Sakata-Sogawa K, Osakada H, Haraguchi T, Awazu A, Ochiai H, Sakata Y, Ochiai K, Toki T, Ito E, Goldberg IG, Tokunaga K, Nakao M, Saitoh N. Matsumori H, et al. Among authors: sakata sogawa k, sakata y. Life Sci Alliance. 2022 Mar 23;5(7):e202101045. doi: 10.26508/lsa.202101045. Print 2022 Jul. Life Sci Alliance. 2022. PMID: 35321919 Free PMC article.
Rationale and Design of Prospective, Multicenter, Double-Arm Clinical Trial to Investigate the Efficacy of Tofogliflozin on Left Ventricular Diastolic Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes Mellitus (TOP-HFPEF Trial).
Ito S, Nakajima Y, Fukuda H, Izumi C, Nakazawa G, Yamashita H, Matsuhisa H, Inoko M, Toyoda S, Takiuchi S, Kataoka T, Izumiya Y, Abe Y, Sozu T, Sakata Y, Emoto M, Inoue T, Kitakaze M. Ito S, et al. Among authors: sakata y. Cardiovasc Drugs Ther. 2024 May 10. doi: 10.1007/s10557-024-07576-y. Online ahead of print. Cardiovasc Drugs Ther. 2024. PMID: 38727896
Impact of Left Atrial Appendage Flow Velocity on Thrombus Resolution and Clinical Outcomes in Patients with Atrial Fibrillation and Silent Left Atrial Thrombi: Insights from the LAT Study.
Okada M, Inoue K, Tanaka N, Tanaka K, Hirao Y, Iwakura K, Egami Y, Masuda M, Watanabe T, Minamiguchi H, Oka T, Hikoso S, Sunaga A, Okada K, Nakatani D, Sotomi Y, Sakata Y; Osaka Cardiovascular Conference (OCVC)-Arrhythmia Investigators. Okada M, et al. Among authors: sakata y. Europace. 2024 May 1:euae120. doi: 10.1093/europace/euae120. Online ahead of print. Europace. 2024. PMID: 38691672
Relationship of interleukin-16 with different phenogroups in acute heart failure with preserved ejection fraction.
Tamaki S, Sotomi Y, Nagai Y, Shutta R, Masuda D, Makino N, Yamashita S, Seo M, Yamada T, Nakagawa A, Yasumura Y, Nakagawa Y, Yano M, Hayashi T, Hikoso S, Nakatani D, Ohtani T, Sakata Y; OCVC‐Heart Failure Investigators. Tamaki S, et al. Among authors: sakata y. ESC Heart Fail. 2024 Apr 30. doi: 10.1002/ehf2.14808. Online ahead of print. ESC Heart Fail. 2024. PMID: 38686566 Free article.
Prognostic impact of heart failure admission in survivors of acute myocardial infarction.
Takeuchi S, Honda S, Nishihira K, Kojima S, Takegami M, Asaumi Y, Saji M, Yamashita J, Hibi K, Takahashi J, Sakata Y, Takayama M, Sumiyoshi T, Ogawa H, Kimura K, Yasuda S; JAMIR Investigators. Takeuchi S, et al. Among authors: sakata y. ESC Heart Fail. 2024 Apr 29. doi: 10.1002/ehf2.14790. Online ahead of print. ESC Heart Fail. 2024. PMID: 38685603 Free article.
2,093 results